M. Caglar et al., Enalapril plus frusemide MAG3 scintigraphy in hypertensive patients with atherosclerosis and moderate renal insufficiency, NUCL MED C, 19(12), 1998, pp. 1135-1140
We performed a retrospective study on 26 patients with moderate renal failu
re (mean GFR = 51 +/- 21 ml min(-1) 1.73 m(-2)), hypertension and atheroscl
erosis. Apart from three patients who had completely normal renal Doppler u
ltrasonography, all patients underwent renal angiography. Three groups of k
idneys with different atherosclerotic renal artery involvement were identif
ied: Group 1, 24 kidneys with no renal artery stenosis (RAS); Group 2, 18 k
idneys with mild (> 25% and < 50% diameter) RAS; and Group 3, 10 kidneys wi
th moderate (> 50% diameter) RAS. We used a two-day protocol with frusemide
plus enalapril Tc-99(m)-MAG3 scintigraphy. The mean parenchymal transit ti
me (MPTT), time to the maximum activity (time to peak) of the renal curve (
T-max), residual activity and split renal uptake were evaluated. The measur
ed parameters did not differ before and after enalapril in Group 1 or in Gr
oup 2. In Group 3, MPTT and residual activity differed significantly (P < 0
.025) before and after enalapril. The T-max before and after enalapril, MPT
T before and after enalapril and residual activity after enalapril differed
significantly (P < 0.05) between Groups 1 and 3 and between Groups 2 and 3
. Threshold values were obtained to maximize diagnostic accuracy. The T-max
, MPTT and residual activity after enalapril gave satisfactory results, and
MPTT performed best with a 75% positive predictive value and a 98% negativ
e predictive value for the diagnosis of renal artery stenosis. We conclude
that MPTT, measured after enalapril administration, is a useful parameter t
o detect renal artery stenosis in patients with hypertension, atheroscleros
is and moderate renal insufficiency. ((C) 1998 Lippincott Williams & Wilkin
s).